Surgical Innovations Group (LSE:SUN) EV-to-EBIT : -8.58 (As of May. 16, 2024)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Surgical Innovations Group's Enterprise Value is £5.11 Mil. Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.60 Mil. Therefore, Surgical Innovations Group's EV-to-EBIT for today is -8.58.

The historical rank and industry rank for Surgical Innovations Group's EV-to-EBIT or its related term are showing as below:

LSE:SUN' s EV-to-EBIT Range Over the Past 10 Years
Min: -46.6 Med: 17.28 Max: 512.7
Current: -8.58

During the past 13 years, the highest EV-to-EBIT of Surgical Innovations Group was 512.70. The lowest was -46.60. And the median was 17.28.

LSE:SUN's EV-to-EBIT is ranked worse than
100% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.415 vs LSE:SUN: -8.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Surgical Innovations Group's Enterprise Value for the quarter that ended in Dec. 2023 was £6.05 Mil. Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.60 Mil. Surgical Innovations Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -9.86%.

Surgical Innovations Group EV-to-EBIT Historical Data

The historical data trend for Surgical Innovations Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group EV-to-EBIT Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-6.92

-4.22

-46.29

363.10

-10.15

Surgical Innovations Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-46.29	-	363.10	-	-10.15

Competitive Comparison of Surgical Innovations Group's EV-to-EBIT

For the Medical Devices subindustry, Surgical Innovations Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Innovations Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's EV-to-EBIT falls into.

Surgical Innovations Group EV-to-EBIT Calculation

Surgical Innovations Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	5.114	/	-0.596
	=	-8.58

Surgical Innovations Group's current Enterprise Value is £5.11 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.60 Mil.

Surgical Innovations Group (LSE:SUN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Surgical Innovations Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.596	/	6.046896
	=	-9.86 %

Surgical Innovations Group's Enterprise Value for the quarter that ended in Dec. 2023 was £6.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.60 Mil.

Surgical Innovations Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group (LSE:SUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.